Search Results: MCHLine

Strengthen the Evidence for Maternal and Child Health Programs

Edit Your Search

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.

Displaying records 1 through 1 (1 total).

Association of Maternal and Child Health Programs . 2021. Perinatal cannabis use in the era of increasing legalization: Considerations for state MCH programs. Washington, DC: Association of Maternal and Child Health Programs , 28 pp.

Annotation: This issue brief is a call to action for maternal and child health (MCH) professionals to be leaders in designing and implementing public health approaches to minimize the potential harms of perinatal cannabis (marijuana) use. The brief describes trends in Cannabis use among pregnant people, addresses the changing policy landscape, and discusses the racial implications of criminalizing the use of drugs among pregnant people and mothers. State MCH program approaches to help prevent eprinatal cannabis use are included.

Contact: Association of Maternal and Child Health Programs, 1825 K Street, N.W., Suite 250, Washington, DC 20006-1202, Telephone: (202) 775-0436 Fax: (202) 478-5120 E-mail: [email protected] Web Site: http://www.amchp.org

Link

Keywords: Cannabis, Illicit drugs, Marijuana, Maternal health, Models, Perinatal care, Pregnancy, Prevention, Substance use

The MCH Digital Library is one of six special collections at Geogetown University, the nation's oldest Jesuit institution of higher education. It is supported in part by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under award number U02MC31613, MCH Advanced Education Policy with an award of $700,000/year. The library is also supported through foundation and univerity funding. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.